Consumer Marketing briefs

Share this article:
Actor Chris Noth, of Sex the City and Law & Order: Criminal Intent fame, has been named Novo Nordisk's latest spokesperson for DTC diabetes campaign, Ask.Screen.Know. The campaign, which launched nationally more than three years ago, works to educate Americans 45 years and older on their risk for diabetes, type 2 in particular.

The UK's Prescription Medicines Code of Practice Authority (PMCPA) slapped Bayer HealthCare over two tweets posted about a melt-in-mouth version of Levitra, for ED, and MS drug Sativex. The Levitra tweet, without citing the product by name, “referred to its qualities, indication and launch,” said the PMCPA, in a way that could lead members of the public to ask their doctors about it.

At Matthew Herper's Forbes blog, former Merck exec Peter DeVilbiss commented: “If there was a regulatory mandate for all pharma companies to cease direct-to-consumer advertising for prescription drugs and vaccines, what would happen? It is not clear to me that this would be a death knell for the industry. I think it's reasonable to assume that revenues would fall, but the big question is whether costs would fall more? I'm not so sure that pharma wouldn't be better off in a few ways.”
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.